PIM
MEDP icon

Plato Investment Management’s Medpace MEDP Stock Holding History

Plato Investment Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-191
Closed -$63.7K – 578
2024
Q4 		$63.7K Sell
191
-165
-46% -$56K ﹤0.01% 484
2024
Q3 		$119K Sell
356
-4
-1% -$1.52K 0.01% 415
2024
Q2 		$148K Buy
360
+165
+85% +$65.3K 0.01% 354
2024
Q1 		$78.8K Buy
195
+52
+36% +$18.3K 0.01% 354
2023
Q4 		$43.8K Buy
+143
New +$38.6K 0.05% 239

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Plato Investment Management's MEDP Position: Q1 2025 in Review

Plato Investment Management sold out of Medpace (MEDP) in Q1 2025, closing a stake of 191 shares — an estimated $63.7K sold.

Plato Investment Management first reported a position in MEDP in Q4 2023 and held it in 5 quarters. The position peaked at $148K in Q2 2024. 586 funds tracked by Wall St. Rank hold MEDP as of Q1 2025.

  • Plato Investment Management reported no remaining Medpace position as of Q1 2025 after selling out during the quarter.
  • Plato Investment Management sold 191 Medpace shares in Q1 2025, an estimated $63.7K.
  • Plato Investment Management first reported a position in Medpace in Q4 2023 and held it in 5 quarters.
  • Plato Investment Management's Medpace position peaked at $148K in Q2 2024.
  • 586 funds tracked by Wall St. Rank held Medpace as of Q1 2025.

Based on Plato Investment Management's 13F filing for Q1 2025, filed 20 May 2025.